Jennison Associates LLC Regenxbio Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$12.89 - $20.82 $6,354 - $10,264	493 Added 1.3%	38,359 $688,000
Q3 2023 Oct 31, 2023	BUY	$16.46 - $19.99 $5,497 - $6,676	334 Added 0.89%	37,866 $623,000
Q2 2023 Aug 03, 2023	BUY	$17.23 - $21.71 $39,697 - $50,019	2,304 Added 6.54%	37,532 $750,000
Q1 2023 Apr 26, 2023	SELL	$18.08 - $24.55 $110,776 - $150,417	-6,127 Reduced 14.82%	35,228 $666,000
Q4 2022 Feb 09, 2023	SELL	$20.4 - $24.73 $21,399 - $25,941	-1,049 Reduced 2.47%	41,355 $937,000
Q3 2022 Nov 01, 2022	SELL	$22.29 - $35.04 $70,525 - $110,866	-3,164 Reduced 6.94%	42,404 $1.12 Million
Q2 2022 Aug 02, 2022	BUY	$19.35 - $35.04 $301,414 - $545,818	15,577 Added 51.94%	45,568 $1.13 Million
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $738,378 - $1.03 Million	29,991 New	29,991 $995,000

191

45.4M

184K

56.7K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $314M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.